Trials / Completed
CompletedNCT01868945
Dose Finding Study in Physically Frail Elderly to Measure 25(OH) Vitamin D Levels After Supplementation With Hy.D Calcifediol 25 SD/S and Vitamin D3
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- dsm-firmenich Switzerland AG · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the dose of Hy.D Calcifediol 25 SD/S (a metabolite of vitamin D3) which will achieve the range of mean serum 25(OH)D between 75-100nmol/L in physically frail elderly people after 24 weeks of daily supplementation with different doses of Hy.D Calcifediol 25 SD/S compared to vitamin D3.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | 5 µg/day Hy.D Calcifediol | 5 µg/day Hy.D Calcifediol taken together with breakfast for a total period of 24 weeks |
| DIETARY_SUPPLEMENT | 10 µg/day Hy.D Calcifediol | 10 µg/day Hy.D Calcifediol taken together with breakfast for a total period of 24 weeks |
| DIETARY_SUPPLEMENT | 15 µg/day Hy.D Calcifediol | 15 µg/day Hy.D Calcifediol taken together with breakfast for a total period of 24 weeks |
| DIETARY_SUPPLEMENT | 20 µg/day vitamin D3 | 20 µg/day vitamin D3 taken together with breakfast for a total period of 24 weeks |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2013-06-05
- Last updated
- 2015-03-27
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01868945. Inclusion in this directory is not an endorsement.